Barinthus Biotherapeutics

BRNS

Market cap $30.2M

Delisted

BRNS was delisted on the 8th of September, 2026.

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	AI 1 Alphabet Inc Mountain View, California	$28.6M	+$25.2M	+1,704,444	New
2	MGIM 2 M&G Investment Management London, United Kingdom	$18.5M	+$16.1M	+1,088,597	New
3	DF 3 DC Funds Mclean, Virginia	$10.8M	+$9.5M	+642,204	New
4	4 Tudor Investment Corp Stamford, Connecticut	$6.01M	+$6.22M	+420,319	New
5	5 Hudson Bay Capital Management Stamford, Connecticut	$3.1M	+$2.8M	+189,301	New
6	MIM 6 Monashee Investment Management Boston, Massachusetts	$2.22M	+$1.96M	+132,184	New
7	7 Millennium Management New York	$2.18M	+$1.93M	+130,137	New
8	8 BlackRock New York	$839K	+$739K	+49,927	New
9	CCM 9 CAAS Capital Management New York	$839K	+$740K	+50,000	New
10	IIM 10 Ipswich Investment Management Beverly, Massachusetts	$726K	+$640K	+43,275	New
11	11 Vontobel Holding Zurich, Switzerland	$671K	+$592K	+40,000	New
12	ACA 12 Arena Capital Advisors Los Angeles, California	$515K	+$454K	+30,698	New
13	BC 13 Brookfield Corp Toronto, Ontario, Canada	$420K	+$370K	+25,000	New
14	14 Squarepoint New York	$420K	+$370K	+25,000	New
15	15 Morgan Stanley New York	$284K	+$250K	+16,881	New
16	CSS 16 Cubist Systematic Strategies Stamford, Connecticut	$194K	+$171K	+11,562	New
17	17 Capstone Investment Advisors New York	$168K	+$148K	+10,000	New
18	GCM 18 Ghisallo Capital Management Boston, Massachusetts	$168K	+$148K	+10,000	New
19	EMG 19 ETF Managers Group Summit, New Jersey	$145K	+$150K	+10,113	New